Isoproterenol

Article Details

Citation

Szymanski MW, Singh DP

Isoproterenol

.

PubMed ID
30252298 [ View in PubMed
]
Abstract

Isoproterenol is a beta-1, and beta-2 adrenergic receptor agonist indicated primarily for bradydysrhythmias. The administration and subsequent post-administration monitoring of this medication are complex and necessitate an interprofessional approach to its usage. This activity covers isoproterenol, including mechanism of action, pharmacology, adverse event profiles, eligible patient populations, contraindications, monitoring, and highlights the role of the interprofessional team in the management of isoproterenol therapy.

DrugBank Data that Cites this Article

Drugs
Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
IsoprenalineBeta-1 adrenergic receptorProteinHumans
Yes
Agonist
Details
IsoprenalineBeta-2 adrenergic receptorProteinHumans
Yes
Agonist
Binder
Details